Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS Pathogens, 20, 5, S. e1012190-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2024
- Event
-
Veröffentlichung
- (who)
-
Public Library of Science (PLoS)
- (when)
-
2024
- Creator
-
Karsten, Christina B.
Büttner, Falk
Cajic, Samanta
Nehlmeier, Inga
Roshani, Berit
Klippert, Antonina
Sauermann, Ulrike
Stolte-Leeb, Nicole
Reichl, Udo
Gerardy-Schahn, Rita
Rapp, Erdmann
Stahl-Hennig, Christiane
Pöhlmann, Stefan
- DOI
-
10.1371/journal.ppat.1012190
- URN
-
urn:nbn:de:bvb:384-opus4-1134846
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Karsten, Christina B.
- Büttner, Falk
- Cajic, Samanta
- Nehlmeier, Inga
- Roshani, Berit
- Klippert, Antonina
- Sauermann, Ulrike
- Stolte-Leeb, Nicole
- Reichl, Udo
- Gerardy-Schahn, Rita
- Rapp, Erdmann
- Stahl-Hennig, Christiane
- Pöhlmann, Stefan
- Universität Augsburg
- Public Library of Science (PLoS)
Time of origin
- 2024
Other Objects (12)
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation
The Neutralization of Egypt.
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation
The Neutralization of Egypt.
Impact of host cell-specific glycosylation differences on SIV infectivity and mucosal transmission
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections
Determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
Clearly different mechanisms of enhancement of short-lived Nef-mediated viral infectivity between SIV and HIV-1
P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
SiV
Güterverzeichnisse Si-V
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
Intramolecular glycosylation